Gout
📧 Sign up to get email alerts when something new happens for Gout.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: A Study to Evaluate Efficacy of Dotinurad and Febuxostat for the Treatment of Participants With Gout [Phase 3]
A Phase 3 trial evaluating the efficacy of dotinurad and febuxostat in participants with gout has completed and posted results.
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: Clinical Efficacy Trial of Burdock Root Extract in Patients With Asymptomatic Hyperuricaemia [NA]
Trial update describes a study evaluating the efficacy of burdock root extract in adults with asymptomatic hyperuricemia. The study is curre…
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients [Phase 3]
LG Chem's Phase 3 trial evaluating tigulixostat in gout patients with allopurinol as control has completed.
-
CLINICAL_TRIALS other · 2025-07-16Clinical Trial Update: Extension Study of ABP-671 in Participants With Gout [Phase 2, Phase 3]
An extension study of ABP-671 for gout has been terminated (Phase 2/Phase 3). The update does not provide further results.
-
EMA approval · 2025-07-14EMA Authorised: Febuxostat Viatris (previously Febuxostat Mylan) (febuxostat) — Viatris Limited
The EMA authorised Febuxostat Viatris (febuxostat) by Viatris Limited for hyperuricemia and gout, including gouty arthritis indications.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Developing A Gout Action Plan in Primary Care Setting in Singapore [NA]
A SingHealth Polyclinics-led clinical trial in Singapore aims to develop a gout action plan for primary care, addressing gout, hyperuricemia…
-
FDA approval · 2025-07-01FDA Approved: COLCHICINE — Supplemental Application (Par Health USA, LLC)
FDA approved a supplemental application for Colchicine from Par Health USA, LLC. The action likely updates the product’s labeling or indicat…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Metformin in Safety and Efficacy in Gouty Patients [Phase 2]
This update announces a Phase 2 clinical trial evaluating metformin for safety and efficacy in patients with gout, currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Comparative Clinical and Biochemical Study Evaluating the Effectiveness of Metformin Versus Febuxostat on Gouty Obese Non-Diabetic Patients [Phase 2]
A Phase 2 clinical trial is evaluating metformin versus febuxostat for gout in obese, non-diabetic patients and is currently recruiting.
-
FDA approval · 2025-06-13FDA Approved: ALLOPURINOL — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Allopurinol from Zydus Lifesciences Limited.
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: The Remote Monitoring of Gout Study [NA]
A clinical trial update regarding a gout study that evaluates remote monitoring for patients initiating urate-lowering therapy. The study is…
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Pilot Study to Explore the Role of Gut Flora in Gout
A pilot clinical trial investigating the role of gut flora in gout has been withdrawn from the registry.
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Using Gout Buddy to Enhance Gout Management [NA]
A planned clinical trial will evaluate the Gout Buddy tool to enhance gout management; recruitment has not yet begun.
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and Hyperuricemia [Phase 1]
Phase 1 clinical trial evaluating safety, tolerability, and pharmacokinetics of the experimental drug SSS11 in patients with gout and hyperu…
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: To Evaluate the Influence of (LUA Probiotics) on Uric Acid
A clinical trial evaluating the influence of LUA Probiotics on uric acid levels in individuals with gout has completed.
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Exploratory Study on the Treatment of Gout With Potassium Citrate Sustained-release Tablets [Phase 4]
An exploratory Phase 4 trial is evaluating potassium citrate sustained-release tablets for gout and hyperuricemia. The study is currently re…
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: Phase II Study to Evaluate Efficacy and Safety of D-0120 in Combination With Allopurinol in Subjects With Gout [Phase 2]
A Phase 2 trial is evaluating the efficacy and safety of D-0120 in combination with allopurinol for gout. The study status is active but not…
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: Maintenance or Withdrawal of Urate Lowering Therapy According to Ultrasound Features in Gout Patients: a Randomised Controlled Trial Stop Treatment In Gout [Phase 2]
A Phase 2 randomized trial evaluating whether to stop or continue urate-lowering therapy in gout patients based on ultrasound features.
-
CLINICAL_TRIALS research · 2025-04-15Clinical Trial Update: Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302) [Phase 3]
Phase 3 trial AR882-302 evaluating AR882 for gout is currently active but not recruiting, with no efficacy or safety results reported in thi…
-
FDA approval · 2025-04-14FDA Approved: ALLOPURINOL — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for Allopurinol from Aurobindo Pharma Limited, authorizing a generic version of allopurinol.
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: Efficacy Anda Safety of Etoricoxib With Betamethasone for the Treatment of Acute Gout Arthritis [Phase 3]
This document describes an ongoing Phase 3 trial evaluating the combination of etoricoxib and betamethasone for acute gout arthritis, with r…
-
CLINICAL_TRIALS trial_result · 2025-03-27Clinical Trial Update: A Dose Finding Study to Assess Efficacy and Safety of IBI128 in Chinese Gout Subjects [Phase 2]
A Phase 2 dose-finding trial evaluating the efficacy and safety of IBI128 in Chinese patients with gout and hyperuricemia has completed.
-
EMA approval · 2025-03-27EMA Authorised: Febuxostat Krka (febuxostat) — Krka, d.d., Novo mesto
The EU authorities authorised Febuxostat Krka for the treatment of hyperuricemia and gout.
-
CLINICAL_TRIALS research · 2025-03-19Clinical Trial Update: Prevalence of Abnormalities in Ultrasonography of Joint and Tendons in Patients With Gout
This clinical trial update describes a study investigating how common ultrasonography-detected abnormalities in joints and tendons are among…
-
FDA approval · 2025-03-14FDA Approved: COLCHICINE — Supplemental Application (Par Health USA, LLC)
FDA approved a supplemental application for colchicine submitted by Par Health USA, LLC. The action pertains to the generic colchicine produ…